Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 358 (LINC00358) is a gene encoding a long intergenic non-coding RNA (lincRNA). LINC00358 belongs to the class of lncRNAs, transcripts longer than 200 nucleotides that do not overlap annotated protein-coding genes. LincRNAs are typically involved in modulating gene expression by chromatin remodeling, transcriptional regulation either in cis (acting locally on neighboring genes) or trans (acting distantly), and may participate in broader epigenetic functions. LINC00358's specific biological role and disease associations have not been clearly established in current literature or databases. While the lncRNA class as a whole is actively investigated in cancer and other diseases for their regulatory functions and biomarker potential, most lincRNAs—including LINC00358—remain uncharacterized functionally and are neither established as therapeutic targets nor as clinical biomarkers.
Not applicable (no drugs known to interact)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 358 (LINC00358).